Titre : Recombinases

Recombinases : Questions médicales fréquentes

Termes MeSH sélectionnés :

Flow Cytometry
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Recombinases : Questions médicales les plus fréquentes", "headline": "Recombinases : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Recombinases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-06", "dateModified": "2025-03-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Recombinases" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Enzymes", "url": "https://questionsmedicales.fr/mesh/D004798", "about": { "@type": "MedicalCondition", "name": "Enzymes", "code": { "@type": "MedicalCode", "code": "D004798", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Holliday junction resolvases", "alternateName": "Holliday Junction Resolvases", "url": "https://questionsmedicales.fr/mesh/D045565", "about": { "@type": "MedicalCondition", "name": "Holliday junction resolvases", "code": { "@type": "MedicalCode", "code": "D045565", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.739.250" } } }, { "@type": "MedicalWebPage", "name": "Integrases", "alternateName": "Integrases", "url": "https://questionsmedicales.fr/mesh/D019426", "about": { "@type": "MedicalCondition", "name": "Integrases", "code": { "@type": "MedicalCode", "code": "D019426", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.739.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Recombinases", "alternateName": "Recombinases", "code": { "@type": "MedicalCode", "code": "D045522", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Ahmed Abd El Wahed", "url": "https://questionsmedicales.fr/author/Ahmed%20Abd%20El%20Wahed", "affiliation": { "@type": "Organization", "name": "Division of Microbiology and Animal Hygiene, Georg-August University, D-37077 Goettingen, Germany." } }, { "@type": "Person", "name": "Jonas Kissenkötter", "url": "https://questionsmedicales.fr/author/Jonas%20Kissenk%C3%B6tter", "affiliation": { "@type": "Organization", "name": "Division of Microbiology and Animal Hygiene, Georg-August University, D-37077 Goettingen, Germany." } }, { "@type": "Person", "name": "Susanne Böhlken-Fascher", "url": "https://questionsmedicales.fr/author/Susanne%20B%C3%B6hlken-Fascher", "affiliation": { "@type": "Organization", "name": "Division of Microbiology and Animal Hygiene, Georg-August University, D-37077 Goettingen, Germany." } }, { "@type": "Person", "name": "Matthew S Forrest", "url": "https://questionsmedicales.fr/author/Matthew%20S%20Forrest", "affiliation": { "@type": "Organization", "name": "TwistDx(TM) Limited, Cambridge, United Kingdom." } }, { "@type": "Person", "name": "Maciej Paszkowski-Rogacz", "url": "https://questionsmedicales.fr/author/Maciej%20Paszkowski-Rogacz", "affiliation": { "@type": "Organization", "name": "Medical Systems Biology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technical University Dresden, 01307 Dresden, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "NO Synthesis but Not Apoptosis, Mitosis or Inflammation Can Explain Correlations between Flow Directionality and Paracellular Permeability of Cultured Endothelium.", "datePublished": "2022-07-22", "url": "https://questionsmedicales.fr/article/35897652", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms23158076" } }, { "@type": "ScholarlyArticle", "name": "Blood speckle imaging compared with conventional Doppler ultrasound for transvalvular pressure drop estimation in an aortic flow phantom.", "datePublished": "2022-07-16", "url": "https://questionsmedicales.fr/article/35840940", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12947-022-00286-1" } }, { "@type": "ScholarlyArticle", "name": "Analysis of airborne sputum droplets flow dynamic behaviors under different ambient conditions and aerosol size effects.", "datePublished": "2022-07-15", "url": "https://questionsmedicales.fr/article/35850221", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.chemosphere.2022.135708" } }, { "@type": "ScholarlyArticle", "name": "Centrifugal disc liquid reciprocation flow considerations for antibody binding to COVID antigen array during microfluidic integration.", "datePublished": "2022-07-12", "url": "https://questionsmedicales.fr/article/35737382", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1039/d2lc00213b" } }, { "@type": "ScholarlyArticle", "name": "LIMITED EVIDENCE SUGGESTS THAT END STAGE KIDNEY DISEASE AND HEMODIALYSIS MAY IMPACT SALIVARY FLOW RATE AND COMPOSITION.", "datePublished": "2022-07-06", "url": "https://questionsmedicales.fr/article/36162886", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jebdp.2022.101757" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Recombinases", "item": "https://questionsmedicales.fr/mesh/D045522" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Recombinases - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Recombinases", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Recombinases", "description": "Comment diagnostiquer une déficience en recombinases ?\nQuels tests sont utilisés pour évaluer l'activité des recombinases ?\nLes symptômes peuvent-ils indiquer un problème de recombinases ?\nQuels marqueurs biologiques sont associés aux recombinases ?\nPeut-on détecter des recombinases par imagerie médicale ?", "url": "https://questionsmedicales.fr/mesh/D045522?mesh_terms=Flow+Cytometry&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Recombinases", "description": "Quels symptômes sont liés à une déficience en recombinases ?\nLes troubles de la recombinaison affectent-ils le système immunitaire ?\nY a-t-il des signes cliniques de dysfonction des recombinases ?\nLes cancers sont-ils liés aux anomalies des recombinases ?\nLes symptômes varient-ils selon le type de recombinase affectée ?", "url": "https://questionsmedicales.fr/mesh/D045522?mesh_terms=Flow+Cytometry&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Recombinases", "description": "Peut-on prévenir les troubles liés aux recombinases ?\nLes tests génétiques peuvent-ils aider à prévenir les troubles ?\nY a-t-il des recommandations pour les familles à risque ?\nL'éducation sur les maladies génétiques est-elle importante ?\nLes vaccinations peuvent-elles prévenir des complications ?", "url": "https://questionsmedicales.fr/mesh/D045522?mesh_terms=Flow+Cytometry&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Recombinases", "description": "Quels traitements existent pour les déficiences en recombinases ?\nPeut-on corriger les anomalies des recombinases par des médicaments ?\nLa thérapie génique est-elle efficace pour les troubles liés aux recombinases ?\nLes traitements préventifs sont-ils disponibles pour les troubles de recombinases ?\nLes greffes de cellules souches peuvent-elles aider ?", "url": "https://questionsmedicales.fr/mesh/D045522?mesh_terms=Flow+Cytometry&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Recombinases", "description": "Quelles complications peuvent survenir avec des troubles de recombinases ?\nLes troubles de recombinases augmentent-ils le risque de cancer ?\nComment les troubles de recombinases affectent-ils la qualité de vie ?\nLes complications sont-elles réversibles ?\nLes troubles de recombinases peuvent-ils affecter la fertilité ?", "url": "https://questionsmedicales.fr/mesh/D045522?mesh_terms=Flow+Cytometry&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Recombinases", "description": "Quels sont les facteurs de risque pour les troubles de recombinases ?\nL'exposition à des agents environnementaux influence-t-elle les troubles ?\nLes facteurs génétiques jouent-ils un rôle dans les troubles de recombinases ?\nLe sexe influence-t-il le risque de troubles de recombinases ?\nL'âge est-il un facteur de risque pour les troubles de recombinases ?", "url": "https://questionsmedicales.fr/mesh/D045522?mesh_terms=Flow+Cytometry&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en recombinases ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses de l'ADN peuvent identifier des anomalies." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'activité des recombinases ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de recombinaison in vitro et des analyses de séquençage sont courants." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils indiquer un problème de recombinases ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies immunitaires ou des troubles génétiques peuvent être des indicateurs." } }, { "@type": "Question", "name": "Quels marqueurs biologiques sont associés aux recombinases ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux anormaux de certains ARN ou protéines peuvent signaler des dysfonctionnements." } }, { "@type": "Question", "name": "Peut-on détecter des recombinases par imagerie médicale ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'imagerie ne peut pas détecter directement les recombinases, mais elle aide à évaluer les effets." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une déficience en recombinases ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des infections fréquentes, des troubles auto-immuns et des cancers peuvent survenir." } }, { "@type": "Question", "name": "Les troubles de la recombinaison affectent-ils le système immunitaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent entraîner une immunodéficience et une susceptibilité accrue aux infections." } }, { "@type": "Question", "name": "Y a-t-il des signes cliniques de dysfonction des recombinases ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies dans les tests sanguins et des symptômes d'inflammation peuvent apparaître." } }, { "@type": "Question", "name": "Les cancers sont-ils liés aux anomalies des recombinases ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des mutations dans les gènes de recombinases peuvent augmenter le risque de cancers." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de recombinase affectée ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes dépendent du type de recombinase et de son rôle dans l'organisme." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles liés aux recombinases ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un diagnostic précoce peut aider à gérer les symptômes." } }, { "@type": "Question", "name": "Les tests génétiques peuvent-ils aider à prévenir les troubles ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques permettent d'identifier les porteurs et de planifier des interventions." } }, { "@type": "Question", "name": "Y a-t-il des recommandations pour les familles à risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les conseils génétiques et le suivi médical régulier sont recommandés pour les familles à risque." } }, { "@type": "Question", "name": "L'éducation sur les maladies génétiques est-elle importante ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une meilleure compréhension des maladies génétiques peut aider à la prévention et à la gestion." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles prévenir des complications ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent réduire le risque d'infections chez les patients immunodéficients." } }, { "@type": "Question", "name": "Quels traitements existent pour les déficiences en recombinases ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les thérapies géniques et les traitements immunologiques sont des options possibles." } }, { "@type": "Question", "name": "Peut-on corriger les anomalies des recombinases par des médicaments ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de médicaments spécifiques pour corriger ces anomalies." } }, { "@type": "Question", "name": "La thérapie génique est-elle efficace pour les troubles liés aux recombinases ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des études montrent des résultats prometteurs, mais des recherches supplémentaires sont nécessaires." } }, { "@type": "Question", "name": "Les traitements préventifs sont-ils disponibles pour les troubles de recombinases ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitements préventifs, mais un suivi médical régulier est recommandé." } }, { "@type": "Question", "name": "Les greffes de cellules souches peuvent-elles aider ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être bénéfiques pour certains patients avec des troubles immunitaires liés." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des troubles de recombinases ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des infections récurrentes, des cancers et des troubles auto-immuns sont possibles." } }, { "@type": "Question", "name": "Les troubles de recombinases augmentent-ils le risque de cancer ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des mutations dans les gènes de recombinases sont souvent associées à divers cancers." } }, { "@type": "Question", "name": "Comment les troubles de recombinases affectent-ils la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent entraîner des limitations physiques, des hospitalisations fréquentes et des douleurs." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Les troubles de recombinases peuvent-ils affecter la fertilité ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles peuvent avoir un impact sur la fertilité, nécessitant une évaluation." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles de recombinases ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents familiaux de maladies génétiques et des mutations spécifiques augmentent le risque." } }, { "@type": "Question", "name": "L'exposition à des agents environnementaux influence-t-elle les troubles ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains agents environnementaux peuvent augmenter le risque de mutations génétiques." } }, { "@type": "Question", "name": "Les facteurs génétiques jouent-ils un rôle dans les troubles de recombinases ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des mutations héréditaires dans les gènes de recombinases sont souvent impliquées." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque de troubles de recombinases ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines conditions peuvent être plus fréquentes chez un sexe, mais cela varie selon les maladies." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour les troubles de recombinases ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles peuvent se manifester plus tard dans la vie, augmentant le risque avec l'âge." } } ] } ] }

Sources (10000 au total)

Blood speckle imaging compared with conventional Doppler ultrasound for transvalvular pressure drop estimation in an aortic flow phantom.

Transvalvular pressure drops are assessed using Doppler echocardiography for the diagnosis of heart valve disease. However, this method is highly user-dependent and may overestimate transvalvular pres... There were no significant differences between pressure drops estimated by Doppler, BSI and ground-truth at the lowest stenotic condition (10.4 ± 1.76, 10.3 ± 1.63 vs. 10.5 ± 1.00 mmHg, respectively; p... BSI accurately estimated pressure drops only up to 10.5 mmHg in controlled phantom conditions of low stenotic burden. Doppler overestimated pressure drops of 20.9 mmHg. Although BSI offers a number of...

LIMITED EVIDENCE SUGGESTS THAT END STAGE KIDNEY DISEASE AND HEMODIALYSIS MAY IMPACT SALIVARY FLOW RATE AND COMPOSITION.

Rodrigues RP, Vidigal MT, Vieira WA, Nascimento GG, Sabino-Silva R, Blumenberg C, Siqueira MF, Siqueira WL, Paranhos LR. Salivary changes in chronic kidney disease and in patients undergoing hemodialy... The work has been partially funded by CAPES-Finance Code 001. The authors have also acknowledged The Brazilian National Council for Scientific and Technological Development (CNPq) and Minas Gerais Sta... Systematic review with meta-analysis of data....

A German Model Project for Workplace Health Promotion-Flow of Communication, Information, and Reasons for Non-Participation in the Offered Measures.

Workplace health promotion (WHP) as a part of workplace health management (WHM) was strengthened in German legislature with the Prevention Act of 2015. However, smaller enterprises often do not offer ... In total, 21 managers or persons responsible for WHP participated in the first online survey between March and April 2020, and 156 employees responded to the second online survey between June and Octo... Most employees knew about the offered measures and that the measures were cost free. There was no significant association between having communicated the offers to the employees and considering them s... For the practical implementation of model projects in MSMEs, special attention should be paid to ensuring opportunity to participate, which may be easier with in-house offers....

Measuring impact of a quality improvement initiative on glaucoma clinic flow using an automated real-time locating system.

Lean methodology helps maximize value by reducing waste, first by defining what value and waste are in a system. In ophthalmology clinics, value is determined by the number of patients flowing through... A total of 6813 clinical visits occurred at a single academic institution's outpatient glaucoma clinic between January 5, 2018 to July 3, 2018. Over that period, 1589 patients comprising 1972 (29%) of... One thousand nine hundred twenty-three visits with 1588 patients were included in the analysis. Mean [SD] age was 65.9 [14.7] years and 892 [56.2%] were women. After the policy change, technician proc... Real-time locating systems are effective at capturing clinical flow data and assessing clinical practice change initiatives. The refraction policy change was associated with reduced technician process...